A review of the practical and clinical implications of the MIRROR study and consider the impact of pegloticase combined with an immunomodulator.
Lana Dykes
Advertisement
Articles by Lana Dykes
The Friday 5 from Rheumatology Network is a list composed by the Rheumatology Network editorial staff aimed at highlighting relevant coverage of the latest news in rheumatology.
The Friday 5 from Rheumatology Network is a list composed by the Rheumatology Network editorial staff aimed at highlighting relevant coverage of the latest news in rheumatology.
Advertisement
Latest Updated Articles
Friday 5 from Rheumatology Network – May 14May 14th 2021
Advertisement
Advertisement
Trending on Medical Economics
1
ACOs are 'the best way to deliver health care,' CMS chief Dr. Oz says
2
As Medicare’s new ACO model begins, kidney care cannot be left behind
3
Why health plans should rethink GLP-1 coverage
4
Medicare’s MIPS program: 10 years, 200 hours a year and a 1% tip
5